Pinewood Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 0.50 M
as on 16-07-2024
- Company Age 26 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 47.02%
(FY 2022)
- Ebitda 47.02%
(FY 2022)
- Net Worth -7.75%
(FY 2022)
- Total Assets -7.72%
(FY 2022)
About Pinewood Diagnostics
The Corporate was formerly known as Ranbaxy Diagnostics Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Meetal Sampat, Prince Elias, and Satish Arora serve as directors at the Company.
- CIN/LLPIN
U85195DL1998PLC095877
- Company No.
095877
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Sep 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pinewood Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meetal Sampat  | Director | 29-Aug-2015 | Current |
| Prince Elias | Additional Director | 24-Jan-2024 | Current |
| Satish Arora | Director | 18-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Pinewood Diagnostics.
Pinewood Diagnostics Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 47.02% increase in profit. The company's net worth dipped by a decrease of 7.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pinewood Diagnostics?
In 2022, Pinewood Diagnostics had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Faststone Mercantile Company Private LimitedActive 18 years 10 months
Prince Elias is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pinewood Diagnostics?
Unlock and access historical data on people associated with Pinewood Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pinewood Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pinewood Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
